eSubmission: Updates of 'Validation Criteria'
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
For medicinal products for human use, the so-called 'electronic Common Technical Document (eCTD)' is used as the standard for dossier submissions. It consists of five modules (modules 1-5). In the middle of the year, a number of updates were published for this, as you could already read under EMA: Update of Module 1. Now, further updates have been published on the EMA's eSubmission website.
Validation criteria
The list of 'Validation Criteria' has been updated so that it is now available in version 8.1. The 'Release notes for version 8.1 of the EU eCTD M1 Validation Criteria (minor correction)' list the new features of the document in the usual manner and emphasise the differences compared to the previous version 8.0. The introduction and transition periods for use have been set for 01 December 2024 for versions v7.1, 8.0 or v8.1. From 01 March 2025, version 8.1 of the 'Validation Criteria' is mandatory.
The information of the updated passages can be found here.
Related GMP News
21.10.2026EMA Clarifies ESMP Reporting for Critical Medicine Shortages
20.10.2026EDQM Updates Guidance on CEP Sister File Applications
20.10.2026EDQM Revises Guidance on Electronic Submissions for CEP Applications
14.10.2026Bioassays in the United States Pharmacopoeia - Two Chapters come into Force in Spring
07.10.2026CEP 2.0: EDQM Updates Guidance on the Use of Certificates of Suitability
23.09.2026IRIS Portal: EMA expands digital Procedure Management